Eliana Janet Sanjinez-Argandonãa

Dr. Eliana Janet Sanjinez-Argandonãa


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAriana Vieira Alves
Ariana Vieira Alves
ESEliana Janet Sanjinez-Argandonãa
Eliana Janet Sanjinez-Argandonãa
ALAdelita Maria Linzmeier
Adelita Maria Linzmeier
Claudia Andrea Lima CardosoClaudia Andrea Lima Cardoso
Claudia Andrea Lima Cardoso
MMMaria Ligia Macedo
Maria Ligia Macedo
Insects have played an important role as human food throughout history, especially in Africa, Asia and Latin America. A good example of edible insects is the mealworm, Tenebrio molitor Linnaeus, 1758 (Coleoptera, Tenebrionidae), which are eaten in Africa, Asia, the Americas and Australia. This species is easily bred in captivity, requiring simple management. The bocaiuva (Acrocomia aculeata (Jacq.) Lodd) is an abundant palm tree found in the Brazilian Cerrado, providing fruits with high nutritional value. The aim of this work was to determine the chemical composition of T. molitor grown in different artificial diets with bocaiuva pulp flour. The nutritional composition, fatty acid composition, antioxidant activity, trypsin activity and anti-nutritional factors of larvae were analyzed. The results showed that mealworms grown on artificial diet with bocaiuva are a good source of protein (44.83%) and lipid (40.45%), with significant levels of unsaturated fatty acids (65.99%), antioxidant activity (4.5 μM Trolox/g of oil extracted from larvae) and absence of anti-nutritional factors. This study indicates a new source of biomass for growing mealworms and shows that it is possible to breed mealworms in artificial diet with bocaiuva flour without compromising the nutritional quality of the larvae.

1 November 2016 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
GTGiseli Karenina Traesel
Giseli Karenina Traesel
SMSara Emilia Lima Tolouei Menegati
Sara Emilia Lima Tolouei Menegati
ASAriany Carvalho dos Santos
Ariany Carvalho dos Santos
RSRoosevelt Isaias Carvalho Souza
Roosevelt Isaias Carvalho Souza
GBGustavo Roberto Villas Boas
Gustavo Roberto Villas Boas
SOSilvia Oesterreich
Silvia Oesterreich

12 June 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
CLCaroline Honaiser Lescano
Caroline Honaiser Lescano
FLFernando Freitas de Lima
Fernando Freitas de Lima
CMCamila B. Mendes-Silvério
Camila B. Mendes-Silvério
AJAlberto F. O. Justo
Alberto F. O. Justo
DBDébora da Silva Baldivia
Débora da Silva Baldivia
IOIvan Oliveira
Ivan Oliveira
Campomanesia adamantium is a medicinal plant of the Brazilian Cerrado. Different parts of its fruits are used in popular medicine to treat gastrointestinal disorders, rheumatism, urinary tract infections and inflammations. Despite its widespread use by the local population, the mechanisms involving platelet aggregation and the inhibition of cyclooxygenase by C. adamantium are unknown. This study evaluated the chemical composition, antioxidant activities and potential benefits of the C. adamantium peel extract (CAPE) and its components in the platelet aggregation induced by arachidonic acid in platelet-rich plasma. Aspects of the pharmacological mechanism were investigated as follows: platelet viability, calcium mobilization, levels of the cyclic nucleotides cAMP and cGMP, thromboxane B2 levels, and the inhibitory effects on COX-1 and COX-2 were studied in vitro and using molecular docking in the catalytic domain of these proteins. The major CAPE constituents standing out from the chemical analysis are the flavonoids, namely those of the flavones and chalcones class. The results showed that CAPE, quercetin and myricetin significantly decreased arachidonic acid-induced platelet aggregation; the assays showed that CAPE and quercetin decreased the mobilization of calcium and thromboxane B2 levels in platelets and increased cAMP and cGMP levels. Moreover, CAPE inhibited the activity of COX-1 and COX-2, highlighting that quercetin could potentially prevent the access of arachidonic acid more to the catalytic site of COX-1 than COX-2. These results highlight CAPE’s potential as a promising therapeutic candidate for the prevention and treatment of diseases associated with platelet aggregation.

1 January 2017 in Food Research International
Verified
Journal Article
Closed access
FLFernando Freitas de Lima
Fernando Freitas de Lima
GTGiseli Karenina Traesel
Giseli Karenina Traesel
SMSara Emilia Lima Tolouei Menegati
Sara Emilia Lima Tolouei Menegati
ASAriany Carvalho dos Santos
Ariany Carvalho dos Santos
RSRoosevelt Isaias Carvalho Souza
Roosevelt Isaias Carvalho Souza
MVMaria Do Carmo Vieira
Maria Do Carmo Vieira

1 June 2015 in Journal of Medicinal Food
Verified
Journal Article
Closed access
CLCaroline Honaiser Lescano
Caroline Honaiser Lescano
RIRenan Donomae Iwamoto
Renan Donomae Iwamoto
ESEliana Janet Sanjinez-Argandonãa
Eliana Janet Sanjinez-Argandonãa
CKCandida Kassuya
Candida Kassuya
Acrocomia aculeata, popularly known as "bocaiuva," is widely acknowledged in culinary and traditional medicines to treat cardiovascular diseases, a combined effect with diuretics that are also used for hypertension. However, there are no scientific data published to support its use as functional food and its ethnopharmacological use. This study intended to determine the composition of fatty acids of the pulp oil and evaluate the diuretic action and anti-inflammatory activity of the in natura and microencapsulated oil orally administrated on rats. The obtained results confirm the prevalence of monounsaturated fatty acids (68.51%), especially oleic acid (65.68%±1.05%), in the oil from the bocaiuva pulp. The in natura A. aculeata oil has diuretic (P<.01) and anti-inflammatory potential, which promoted a marked inhibition on the hind paw edema induced by carrageenan (67%±7% after 2 h) (P<.01). In addition, results show that the oral administration of the bocaiuva oil at 300 (P<.05) and 700 (P<.05) mg/kg doses significantly inhibited the leukocyte migration induced by carrageenan to the pleural cavity in rats. The inhibitions equaled 91%±3% and 81%±16%, respectively. The microencapsulated oil also showed antiedematogenic (P<.01) as well as diuretic activities (P<.01). The microencapsulation by complex coacervation was shown to be a technique that favors the bioavailability and preservation of bioactive components of the bocaiuva oil.

1 December 2012 in Food Chemistry
Verified
Journal Article
Closed access
CBCaroline A. Breda
Caroline A. Breda
ESEliana Janet Sanjinez-Argandonãa
Eliana Janet Sanjinez-Argandonãa
CCCamila de A.C. Correia
Camila de A.C. Correia